Muirfield Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$272K Sell
2,120
-15
-0.7% -$1.76K 0.18% 68
2026
Q1
$257K Buy
2,135
+17
+0.8% +$1.96K 0.19% 69
2025
Q4
$223K Buy
+2,118
New +$199K 0.16% 71
2025
Q3
Sell
-3,746
Closed -$297K 74
2025
Q2
$297K Buy
3,746
+36
+1% +$2.86K 0.24% 59
2025
Q1
$333K Buy
3,710
+29
+0.8% +$2.71K 0.28% 57
2024
Q4
$366K Buy
3,681
+26
+0.7% +$2.68K 0.3% 52
2024
Q3
$415K Buy
3,655
+22
+0.6% +$2.61K 0.35% 48
2024
Q2
$450K Buy
3,633
+21
+0.6% +$2.71K 0.42% 42
2024
Q1
$477K Buy
3,612
+24
+0.7% +$2.96K 0.46% 42
2023
Q4
$391K Buy
+3,588
New +$372K 0.41% 45

Other funds holding MRK

Muirfield Wealth Advisors's MRK Position: Q2 2026 in Review

Muirfield Wealth Advisors reduced its Merck (MRK) stake by 0.7% in Q2 2026, selling an estimated $1.76K and leaving 2,120 shares worth $272K. The position accounts for 0.18% of the portfolio, ranked #68.

Muirfield Wealth Advisors first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. The position peaked at $477K in Q1 2024. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Muirfield Wealth Advisors held 2,120 shares of Merck worth $272K as of Q2 2026.
  • Muirfield Wealth Advisors sold 15 Merck shares in Q2 2026, an estimated $1.76K.
  • Merck made up 0.18% of Muirfield Wealth Advisors's portfolio in Q2 2026, its #68 holding.
  • Muirfield Wealth Advisors first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • Muirfield Wealth Advisors's Merck position peaked at $477K in Q1 2024.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Muirfield Wealth Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.